CareCloud Inc

CCLDHealthcare·Health Information Services·USA·Micro·NASD·Nov 12 • 3:59 PM ET

2.64-0.01 (-0.38%)

2026-11-13 13:06 CET

Market cap

$112.33M

Revenue, TTM

131.30 USD m

Net income, TTM

5.45 USD m

Free cash flow, TTM

21.61 USD m

EPS diluted, TTM

0.13

Price / earnings

20.61

Compare

Price

CCLD against its 20, 50 and 200-day averages

Terms2050200MissEarnings

Patternshover a marker to name it

30.7% under the 52-week high of 3.81 on 26 Mar 2026. 52-week low 1.67 on 3 Nov 2026. Last 15 sessions, 68.6% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 6
CANSLIM 3 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 3 of 6 — fails: 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; RSI (14): Not Overbought (<60)
Minervini 1 of 4 — fails: 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 3 of 5 — fails: 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 2 of 5 — fails: Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 4 of 4
Quality 2 of 5 — fails: Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); Current Ratio: Over 1
Value 1 of 4 — fails: P/E: Under 15; P/B: Under 2; Debt/Equity: Low (<0.1)
Income 2 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%
Small Cap 2 of 4 — fails: Average Volume: Over 500K; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; Average Volume: Over 500K

Profile

CCLD

52-week range, 45% of the way up

1.673.81

CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.

Employees	3650
IPO	Jul 23, 2014
Beta	1.53
ATR, 14d	0.15
Rel volume	0.00
Short float	1.90%
Insider own	15.72%
Inst own	22.25%

Snapshot

6 groups

Valuation

Index	-
Market Cap	$112.33M
Enterprise Value	150.50M
Income	5.45M
Sales	131.30M
Book / share	0.53
Cash / share	0.11
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	3650
IPO	Jul 23, 2014

Ratios

Price / earnings	20.61
Forward price / earnings	9.10
Price / earnings / growth	0.17
Price / sales	0.86
Price / book	4.97
Price / cash	24.21
Price / free cash flow	5.20
Value / cash profit	4.98
Value / sales	1.15
Quick Ratio	0.85
Current Ratio	0.87
Debt / equity	1.89
Long-term debt / equity	1.35
Options and short	Yes / Yes

Earnings

Earnings / share	0.13
Earnings next year	0.29
Earnings next quarter	0.07
Earnings this year	55.00%
Earnings next year	87.10%
Earnings growth, 5 years	54.67%
Past earnings growth	- -
Past sales growth	-4.61% 2.77%
Earnings vs last year	214.99%
Sales vs last year	14.86%
Earnings vs last quarter	146.25%
Sales vs last quarter	8.56%
Earnings	Nov 05 BMO
Surprise	0.00% 0.67%

Ownership

Insiders own	15.72%
Insider trades	0.00%
Institutions own	22.25%
Institution trades	-8.65%
Return on assets	10.87%
Return on equity	24.02%
Return on capital	18.17%
Gross Margin	35.68%
Operating margin	10.02%
Profit Margin	4.15%
20-day average	33.03%
50-day average	30.05%
200-day average	7.56%

Technical

Shares out	42.55M
Shares floating	35.86M
Short / float	1.90%
Short ratio	1.85
Short interest	0.68M
52-week high	3.81 -30.7%
52-week low	1.67 +58.1%
Volatility	9.81% 6.79%
Average range	0.15
Strength index	77.67
Market sensitivity	1.53
Relative volume	0.00
Avg Volume	366.77K
Volume	0

Performance

Perf Week	22.22%
Perf Month	49.15%
Perf Quarter	1.93%
Perf Half Y	23.36%
Perf YTD	-9.59%
Perf Year	-17.63%
Perf 3Y	123.73%
Perf 5Y	-65.76%
Perf 10Y	200.00%
Recommendation	1.00
Target Price	7.00
Prev Close	2.64
Price	2.64
Change %	0.00%

Analyst ratings

latest 1 of 1

Date	Action	Analyst	Rating change	Target	Implied
Nov 13, 2024	Downgrade	ROTH MKM	Buy → Neutral	$5 → $3.50	+32.6%

Date

Action

Analyst

Rating change

Target

Implied

Nov 13, 2024

Downgrade

ROTH MKM

Buy → Neutral

$5 → $3.50

+32.6%

Peers

Mkt cap

Ticker	Company	Mkt cap
WAY	Waystar Holding Corp	5.41B
PHR	Phreesia Inc	780.24M
HCAT	Health Catalyst Inc	103.57M
DH	Definitive Healthcare Corp	181.57M
HCTI	Healthcare Triangle Inc	3.46M
EVH	Evolent Health Inc	538.38M
HSTM	Healthstream Inc	866.61M
AMWL	American Well Corp	207.16M
DOCS	Doximity Inc	5.92B

Ticker

Company

Mkt cap

WAY

Waystar Holding Corp

5.41B

PHR

Phreesia Inc

780.24M

HCAT

Health Catalyst Inc

103.57M

Definitive Healthcare Corp

181.57M

HCTI

Healthcare Triangle Inc

3.46M

EVH

Evolent Health Inc

538.38M

HSTM

Healthstream Inc

866.61M

AMWL

American Well Corp

207.16M

DOCS

Doximity Inc

5.92B

Insider trading

latest 14 of 17

Insider	Relationship	Date	Transaction	Shares	Total held	Form
BUSQUET ANNE	Director	Aug 08 '26	Option Exercise	7,500	308,888	Aug 10 09:30 PM
KORN BILL	Director	Aug 08 '26	Option Exercise	7,500	225,383	Aug 10 09:30 PM
MUNTER CAMERON	Director	Aug 08 '26	Option Exercise	7,500	216,500	Aug 10 09:30 PM
Sharnak Lawrence Steven	Director	Aug 08 '26	Option Exercise	7,500	141,500	Aug 10 09:30 PM
MUNTER CAMERON	Director	Jul 31 '26	Option Exercise	6,250	209,000	Jul 31 09:30 PM
KORN BILL	Director	Jul 31 '26	Option Exercise	6,250	217,883	Jul 31 09:30 PM
Sharnak Lawrence Steven	Director	Jul 31 '26	Option Exercise	6,250	134,000	Jul 31 09:30 PM
BUSQUET ANNE	Director	Jul 31 '26	Option Exercise	6,250	301,388	Jul 31 09:30 PM
Sharnak Lawrence Steven	Director	Feb 08 '26	Option Exercise	7,500	127,750	Feb 10 09:30 PM
MUNTER CAMERON	Director	Feb 08 '26	Option Exercise	7,500	202,750	Feb 10 09:30 PM
BUSQUET ANNE	Director	Feb 08 '26	Option Exercise	7,500	295,138	Feb 10 09:30 PM
KORN BILL	Director	Feb 08 '26	Option Exercise	7,500	211,633	Feb 10 09:30 PM
KORN BILL	Director	Jan 31 '26	Option Exercise	6,250	204,133	Feb 03 09:30 PM
BUSQUET ANNE	Director	Jan 31 '26	Option Exercise	6,250	287,638	Feb 03 09:30 PM

Held by

AUM

Ticker	Company	AUM
VTI	Vanguard Morningstar Total Stock Market ETF	AUM: 696.31B
AVUV	Avantis U.S. Small Cap Value ETF	AUM: 33.08B
VXF	Vanguard Extended Market Index ETF	AUM: 30.79B
DFAS	U.S. Small Cap Portfolio-ETF Class Shares	AUM: 15.64B
BSVO	EA Bridgeway Omni Small-Cap Value ETF	AUM: 2.45B
IWC	iShares Micro-Cap ETF	AUM: 1.23B
DFMC	U.S. Micro Cap Portfolio ETF Class Shares	AUM: 213.58M
DFSV	US Small Cap Value Portfolio ETF Class Shares	AUM: 8.56B
BUSM	EA Bridgeway Ultra-Small Company Market ETF	AUM: 112.81M
AVSC	Avantis U.S Small Cap Equity ETF	AUM: 3.33B

Ticker

Company

AUM

VTI

Vanguard Morningstar Total Stock Market ETF

AUM: 696.31B

AVUV

Avantis U.S. Small Cap Value ETF

AUM: 33.08B

VXF

Vanguard Extended Market Index ETF

AUM: 30.79B

DFAS

U.S. Small Cap Portfolio-ETF Class Shares

AUM: 15.64B

BSVO

EA Bridgeway Omni Small-Cap Value ETF

AUM: 2.45B

IWC

iShares Micro-Cap ETF

AUM: 1.23B

DFMC

U.S. Micro Cap Portfolio ETF Class Shares

AUM: 213.58M

DFSV

US Small Cap Value Portfolio ETF Class Shares

AUM: 8.56B

BUSM

EA Bridgeway Ultra-Small Company Market ETF

AUM: 112.81M

AVSC

Avantis U.S Small Cap Equity ETF

AUM: 3.33B

News

latest 14 of 200

Nov-11-26 08:00AMCareCloud Accelerates Wound Care Expansion with New Clients, EHR Integration and Multimillion-Dollar Payer Client Audit Wins (GlobeNewswire)
Nov-05-26 10:58AMCareCloud Posts Record Profits On Margin Gains, But Slowing Revenue And Unchanged Guidance Leave A Sold-Off Stock Unconvinced (Earnings Whispers) +20.00%
07:00AMCareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA (GlobeNewswire)
Oct-28-26 01:23PMCareCloud Must Prove Its Back-Half Ramp Is Real After A Bruising Quarter (Earnings Whispers)
Oct-27-26 08:00AMCareCloud Appoints Mitchell Brie as Chief Compliance Officer to Support Compliance Services Growth (GlobeNewswire)
Oct-15-26 08:00AMCareCloud to Announce Third Quarter 2026 Results on November 5, 2026 (GlobeNewswire) +9.04%
Sep-29-26 08:30AMCareCloud Promotes Bonnie Boyer to Chief Financial Officer to Lead the Next Growth Phase (GlobeNewswire)
Aug-18-26 08:00AMKabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy (GlobeNewswire)
Aug-06-26 07:16PMCareCloud Inc (CCLD) (Q2 2026) Earnings Call Highlights: Strategic Investments Drive Growth ... (GuruFocus.com) -8.66% +13.36%
07:00AMCareCloud Reports Second Quarter 2026 Results (GlobeNewswire)
Jul-16-26 08:00AMCareCloud to Announce Second Quarter 2026 Results on August 6, 2026 (GlobeNewswire)
Jun-08-26 08:00AMEmpower, a CareCloud Company, Helps Wound-Care Provider Reverse More Than $1 Million in Alleged Overpayments (GlobeNewswire)
Jun-05-26 08:00AMCareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy (GlobeNewswire)
May-26-26 08:00AMCareCloud Acquires Empower Healthcare & Compliance Partners, adding a High-Growth Compliance Business to its AI-powered Platform (GlobeNewswire)

Key figures

Revenue, TTM	131.30
Net income, TTM	5.45
EPS diluted, TTM	0.13
EBIT, TTM	13.15
Free cash flow, TTM	21.61
Gross margin	35.68%
Operating margin	10.02%
Net margin	4.15%
Market cap, statement	112.33
Price / earnings	20.61
Sales Y/Y, TTM	14.86%

Statement money is USD millions. A margin is a percent. EPS is per share. P/E and sales growth are the snapshot.

Quarterly earnings

2026Q3 EPS 0.100 matched 0.100, from 0.040 a year earlier. Sales 33.73 beat 33.50, from 31.07 a year earlier

EPS

Sales, USD millions

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

Period	Reported	EPS adjusted	EPS est	EPS reported	Sales act, USD m	Sales est, USD m	Surprise	Year-ago quarter	Analysts	Next session
2026Q3ended 2026-09-30	2026-11-05 08:30	0.100	0.100	0.100	33.73	33.50	EPS 0.0% · sales +0.7%	vs 2025Q3, year-ago quarter · EPS +150.0% · sales +8.6%	2	Open +16.67% vs SPY -0.17%. Close +20.00% vs SPY -4.41%
2026Q2ended 2026-06-30	2026-08-06 08:30	0.000	0.023	0.004	31.88	31.85	EPS -100.0% · sales +0.1%	vs 2025Q2, year-ago quarter · EPS -100.0% · sales +16.4%	3	Open -13.39% vs SPY +0.05%. Close -8.66% vs SPY -0.16%
2026Q1ended 2026-03-31	2026-05-07 08:30	-0.010	-0.007	-0.010	31.27	30.51	EPS +49.3% · sales +2.5%	vs 2025Q1, year-ago quarter · EPS -75.0% · sales +13.3%	3	Open -4.01% vs SPY +0.17%. Close -17.39% vs SPY -0.31%
2025Q4ended 2025-12-31	2026-03-12 08:30	0.040	0.040	0.036	34.42	32.09	EPS 0.0% · sales +7.3%	vs 2024Q4, year-ago quarter · EPS - · sales +21.9%	3	Open +9.40% vs SPY -0.76%. Close +9.40% vs SPY -1.52%
2025Q3ended 2025-09-30	2025-11-06 08:30	0.040	0.025	0.040	31.07	28.17	EPS +60.0% · sales +10.3%	vs 2024Q3, year-ago quarter · EPS -200.0% · sales +8.8%	2	Open +17.29% vs SPY -0.16%. Close +17.63% vs SPY -1.07%
2025Q2ended 2025-06-30	2025-08-05 08:30	0.040	0.010	0.036	27.38	26.69	EPS +300.0% · sales +2.6%	vs 2024Q2, year-ago quarter · EPS -128.6% · sales -2.6%	2	Open +5.88% vs SPY +0.10%. Close 0.00% vs SPY -0.51%
2025Q1ended 2025-03-31	2025-05-06 08:30	-0.040	-0.050	-0.036	27.60	25.65	EPS -20.0% · sales +7.6%	vs 2024Q1, year-ago quarter · EPS +100.0% · sales +6.3%	3	Open +10.57% vs SPY -0.99%. Close +22.29% vs SPY -0.84%
2024Q4ended 2024-12-31	2025-03-13 08:30	0.000	-0.058	0.001	28.24	27.99	EPS -100.0% · sales +0.9%	vs 2023Q4, year-ago quarter · EPS -100.0% · sales -0.6%	5	Open +45.00% vs SPY -0.07%. Close 0.00% vs SPY -1.33%
2024Q3ended 2024-09-30	2024-11-12 08:30	-0.040	-0.137	-0.041	28.55	28.54	EPS -70.7% · sales +0.0%	vs 2023Q3, year-ago quarter · EPS -90.5% · sales -2.5%	4	Open +28.74% vs SPY -0.01%. Close +21.46% vs SPY -0.31%
2024Q2ended 2024-06-30	2024-08-13 08:30	-0.140	-0.030	-0.139	28.10	28.09	EPS +366.7% · sales +0.0%	vs 2023Q2, year-ago quarter · EPS -62.2% · sales -4.3%	4	Open +5.88% vs SPY +0.61%. Close +12.75% vs SPY +1.64%
2024Q1ended 2024-03-31	2024-05-14 08:30	-0.020	-0.290	-0.015	25.96	26.04	EPS -93.1% · sales -0.3%	vs 2023Q1, year-ago quarter · EPS -92.9% · sales -13.5%	4	Open -1.72% vs SPY +0.04%. Close -21.12% vs SPY +0.46%
2023Q4ended 2023-12-31	2024-03-21 08:30	-3.000	-0.343	-2.999	28.40	30.89	EPS +773.9% · sales -8.1%	vs 2022Q4, year-ago quarter · EPS +1263.6% · sales -12.7%	3 EPS · 4 sales	Open +2.52% vs SPY +0.56%. Close -6.72% vs SPY +0.33%
2023Q3ended 2023-09-30	2023-11-02 08:30	-0.420	-0.332	-0.423	29.28	30.43	EPS +26.5% · sales -3.8%	vs 2022Q3, year-ago quarter · EPS +133.3% · sales -13.2%	5	-
2023Q2ended 2023-06-30	2023-08-03 08:30	-0.370	-0.274	-0.368	29.36	31.31	EPS +35.0% · sales -6.2%	vs 2022Q2, year-ago quarter · EPS +428.6% · sales -21.1%	5	-
2023Q1ended 2023-03-31	2023-05-04 08:30	-0.280	-0.297	-0.281	30.00	30.88	EPS -5.6% · sales -2.8%	vs 2022Q1, year-ago quarter · EPS +47.4% · sales -15.1%	6	-
2022Q4ended 2022-12-31	2023-03-02 08:30	-0.220	-0.214	-0.220	32.53	33.37	EPS +2.8% · sales -2.5%	vs 2021Q4, year-ago quarter · EPS +2100.0% · sales -13.2%	5	-

Annual earnings

2025FY EPS 0.100 beat 0.095, from -0.280 a year earlier. Sales 120.5 beat 117.88, from 110.84 a year earlier

EPS

Sales, USD millions

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

Period	EPS adjusted	EPS est	EPS reported	Sales act, USD m	Sales est, USD m	P/E, earnings feed
2028FYestimate	-	0.370	-	-	141.51	7.14
2027FYestimate	-	0.290	-	-	135.52	9.10
2026FYestimate	-	0.155	-	-	128.4	17.03
2025FY	0.100	0.095	0.100	120.5	117.88	29.20
2024FY	-0.280	-0.282	-0.276	110.84	110.59	-
2023FY	-4.110	-1.413	-4.107	117.1	119.52	-
2022FY	-0.670	-0.658	-0.668	138.83	139.67	-
2021FY	-0.770	-0.918	-0.771	139.6	139.26	-
2020FY	-1.790	-1.863	-1.790	105.12	105.12	-
2019FY	-0.600	-0.554	-0.600	64.44	64.82	-
2018FY	0.290	-0.610	-0.594	50.55	50.05	13.10
2017FY	0.000	-0.040	-0.690	31.81	31.80	-
2016FY	-0.190	-0.730	-0.950	24.49	23.70	-
2015FY	-0.130	-0.505	-0.500	23.08	23.00	-
2014FY	-0.210	-0.850	-0.640	18.30	18.30	-

Quarterly results

2026Q3 revenue 33.73, from 31.07 a year earlier. Operating margin 19.6%, from 11.7% a year earlier

Revenue, USD millions

Operating margin

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 0.16 per share.

Period	Type	Scale	Date	Mean	vs prior date
2026FY	E	per share	2026-11-06	0.16	-45.6%
2026Q4	E	per share	2026-11-06	0.07	-38.1%
2026FY	R	per share	2026-11-06	0.16	-45.6%
2026Q4	R	per share	2026-11-06	0.07	-38.1%
2026Q4	S	per share	2026-11-06	31.53	-1.7%
2026FY	S	-	2026-11-06	128.4	-0.8%
2026Q3	E	per share	2026-10-20	0.10	0.0%
2026Q3	R	per share	2026-10-20	0.10	0.0%
2026Q3	S	per share	2026-10-20	33.50	0.0%
2026Q2	E	per share	2026-07-22	0.02	0.0%
2026Q2	R	per share	2026-07-22	0.02	0.0%
2026Q2	S	per share	2026-07-21	31.85	0.0%
2026Q1	S	per share	2026-04-20	30.51	+0.0%
2026Q1	E	per share	2026-04-17	-0.01	-150.4%
2026Q1	R	per share	2026-04-17	-0.01	-150.4%
2025FY	E	per share	2026-01-20	0.10	0.0%
2025Q4	E	per share	2026-01-20	0.04	0.0%
2025FY	R	per share	2026-01-20	0.10	0.0%
2025Q4	R	per share	2026-01-20	0.04	0.0%
2025Q4	S	per share	2026-01-20	32.09	0.0%
2025FY	S	-	2026-01-20	117.88	0.0%
2025Q3	E	per share	2025-09-03	0.03	-28.6%
2025Q3	R	per share	2025-09-03	0.03	-28.6%
2025Q3	S	per share	2025-08-26	28.17	+1.8%
2025Q2	E	per share	2025-07-20	0.01	0.0%
2025Q2	R	per share	2025-07-20	0.01	0.0%
2025Q2	S	per share	2025-07-20	26.69	0.0%
2025Q1	E	per share	2025-04-25	-0.05	+7.1%
2025Q1	R	per share	2025-04-25	-0.05	+7.1%
2025Q1	S	per share	2025-04-25	25.65	+0.0%
2024FY	E	per share	2025-01-28	-0.28	0.0%
2024Q4	E	per share	2025-01-28	-0.06	0.0%
2024FY	R	per share	2025-01-28	-0.28	0.0%
2024Q4	R	per share	2025-01-28	-0.06	0.0%
2024Q4	S	per share	2025-01-27	27.99	0.0%
2024FY	S	-	2025-01-27	110.59	0.0%
2024Q3	E	per share	2024-11-06	-0.14	0.0%
2024Q3	R	per share	2024-11-06	-0.14	0.0%
2024Q3	S	per share	2024-11-06	28.54	0.0%
2024Q2	E	per share	2024-07-28	-0.03	0.0%
2024Q2	R	per share	2024-07-28	-0.03	0.0%
2024Q2	S	per share	2024-07-28	28.09	0.0%
2024Q1	E	per share	2024-03-22	-0.29	+5.5%
2024Q1	R	per share	2024-03-22	-0.29	+5.5%
2024Q1	S	per share	2024-03-22	26.04	+0.6%
2023FY	S	-	2024-03-17	119.52	0.0%
2023FY	E	per share	2024-01-29	-1.41	0.0%
2023FY	R	per share	2024-01-29	-1.41	0.0%

Estimate history

Annual
Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM	MRQ
EPS per share	-0.69	-0.594	-0.6	-1.79	-0.771	-0.668	-4.107	-0.276	0.103	0.1281	-
Sales USD millions	32	51	64	105	140	139	117	111	120	131	-
Shares million shares	12	12	12	13	15	15	16	16	42	-	43

Quarterly
Metric	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
EPS per share	-0.041	0.001	-0.036	0.036	0.04	0.036	-0.01	0.004	0.099
Sales USD millions	29	28	28	27	31	34	31	32	34
Shares million shares	16	16	42	42	42	42	42	42	43

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	TTM	2025FY12/31/2025	2024FY12/31/2024	2023FY12/31/2023	2022FY12/31/2022	2021FY12/31/2021	2020FY12/31/2020	2019FY12/31/2019	2018FY12/31/2018
Total Revenue	131.30	120.50+8.7%	110.84-5.3%	117.06-15.7%	138.83-0.6%	139.60+32.8%	105.12+63.1%	64.44+27.5%	50.55
Cost of Goods Sold Incl. D&A	84.46	79.42+5.9%	74.98-12.0%	85.22-11.4%	96.16-3.0%	99.11+32.6%	74.73+69.1%	44.19+29.6%	34.11
Gross Profit	46.84	41.08+14.6%	35.85+12.6%	31.84-25.4%	42.67+5.4%	40.49+33.2%	30.40+50.1%	20.25+23.2%	16.44
Selling, General and Administrative Excl. Other	33.69	28.97+11.0%	26.09-26.6%	35.56-4.2%	37.13+2.9%	36.10+0.2%	36.01+78.4%	20.18+8.1%	18.66
Research and Development	8.21	6.38+68.8%	3.78-20.3%	4.74+7.7%	4.40-0.2%	4.41-52.6%	9.31+970.1%	0.87-15.5%	1.03
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	13.15	12.12+24.2%	9.76	-3.72-167.3%	5.53+26.3%	4.38	-5.61-8114.3%	0.07	-2.22
Interest Expense	2.69	0.29-67.8%	0.90-24.4%	1.19+190.2%	0.41-10.9%	0.46-6.1%	0.49+28.9%	0.38+8.6%	0.35
Unusual Expense	0.59	0.76+18.8%	0.64-98.5%	43.39	-1.08-227.1%	0.85-68.0%	2.66	0.00-100.0%	0.32
Net Income Before Taxes	10.01	11.00+37.3%	8.01	-49.04-974.2%	5.61+87.6%	2.99	-8.71	-0.68	-2.30
Income Taxes	0.35	0.20+25.0%	0.16	-0.36-300.0%	0.18+12.5%	0.16+60.0%	0.10-47.4%	0.19	-0.16
Consolidated Net Income	9.66	10.80+37.6%	7.85	-48.67-996.3%	5.43+91.2%	2.84	-8.81	-0.87	-2.14
Net Income From Continuing Operations	9.66	10.80+37.6%	7.85	-48.67-996.3%	5.43+91.2%	2.84	-8.81	-0.87	-2.14
Net Income	5.45	3.89	-4.46	-64.35	-10.09	-11.22	-22.69	-7.26	-6.96
EPS (Recurring) per share	0.14	0.12	-0.25	-2.17	-0.72	-0.73	-1.64	-0.60	-0.57
EPS (Basic, Before Extraordinaries) per share	0.13	0.10	-0.28	-4.11	-0.67	-0.77	-1.79	-0.60	-0.59
EPS (Diluted) per share	0.13	0.10	-0.28	-4.11	-0.67	-0.77	-1.79	-0.60	-0.59
EBITDA	30.22	28.84+11.4%	25.90+101.9%	12.83-37.6%	20.55+2.0%	20.15+180.6%	7.18+44.8%	4.96+687.3%	0.63
Non-Operating Income (Expense)	0.14	-0.07	-0.21	-0.73	-0.60	-0.08-260.0%	0.05	-0.36-160.0%	0.60
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Option Compensation Expense	0.27	0.36+300.0%	0.09-97.7%	3.86-0.5%	3.88-1.5%	3.94-17.1%	4.75+102.1%	2.35+20.5%	1.95
Price To Earnings Ratio ratio statement ratio, not the snapshot	20.61	20.61	-	-	-	-	-	-	-
Price To Sales Ratio ratio	0.66	0.92	0.53	0.20	0.31	0.66	1.09	0.76	0.88
Gross Margin %	35.68	34.09	32.35	27.20	30.73	29.00	28.91	31.42	32.52
Operating Margin %	10.02	10.05	8.81	-3.18	3.99	3.14	-5.34	0.10	-4.40
Net Margin %	4.15	3.23	-4.02	-54.97	-7.26	-8.03	-21.58	-11.26	-13.77
Shares Outstanding million shares	42.55	42.44+161.0%	16.26+2.4%	15.88+4.3%	15.23+2.1%	14.92+11.5%	13.38+9.3%	12.24+3.5%	11.83
Market Capitalization	112.33	112.33+88.8%	59.50+146.6%	24.13-43.6%	42.77-54.5%	94.01-21.4%	119.61+141.1%	49.61+10.2%	45.01

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	2026Q39/30/2026	2026Q26/30/2026	2026Q13/31/2026	2025Q412/31/2025	2025Q39/30/2025	2025Q26/30/2025	2025Q13/31/2025	2024Q412/31/2024
Total Revenue	33.73+8.6%	31.88+16.4%	31.27+13.2%	34.42+21.9%	31.07+8.8%	27.38-2.5%	27.63+6.4%	28.24-0.6%
Cost of Goods Sold Incl. D&A	19.87-1.9%	21.19+18.6%	20.89+11.1%	22.51+23.3%	20.25+8.5%	17.86-5.8%	18.80-1.6%	18.26-13.4%
Gross Profit	13.85+28.0%	10.69+12.3%	10.38+17.6%	11.92+19.4%	10.82+9.5%	9.52+4.3%	8.83+28.7%	9.98+36.3%
Selling, General and Administrative Excl. Other	7.23+0.4%	8.70+34.1%	9.17+37.1%	8.59+33.8%	7.20+10.1%	6.49-3.7%	6.69+4.7%	6.42-22.3%
Research and Development	1.05-33.5%	2.19+114.7%	2.42+95.2%	2.54+151.5%	1.58+97.5%	1.02-2.9%	1.24+36.3%	1.01-16.5%
Other Operating Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income	6.62+82.9%	1.99-34.3%	1.22-43.3%	3.32-6.7%	3.62+8.4%	3.03+26.2%	2.15+367.4%	3.56
Interest Expense	1.80+1100.0%	0.81+1057.1%	0.060.0%	0.01-85.7%	0.15-16.7%	0.07-75.9%	0.06-83.3%	0.07-80.6%
Unusual Expense	0.04-90.2%	0.13+333.3%	0.21+61.5%	0.20+100.0%	0.41+412.5%	0.03-76.9%	0.13-60.6%	0.10-99.8%
Net Income Before Taxes	4.85+56.5%	1.22-58.5%	0.97-51.3%	2.96-11.4%	3.10-1.9%	2.94+71.9%	1.99	3.34
Income Taxes	0.13+225.0%	0.10+150.0%	0.05+25.0%	0.07+75.0%	0.040.0%	0.040.0%	0.040.0%	0.04
Consolidated Net Income	4.73+54.6%	1.12-61.4%	0.92-52.8%	2.89-12.4%	3.06-1.9%	2.90+73.7%	1.95	3.30
Net Income From Continuing Operations	4.73+54.6%	1.12-61.4%	0.92-52.8%	2.89-12.4%	3.06-1.9%	2.90+73.7%	1.95	3.30
Net Income	4.19+146.5%	0.18-88.3%	-0.44	1.52+15100.0%	1.70	1.54	-0.86	0.01
EPS (Recurring) per share	0.10+100.0%	0.01-75.0%	-0.01	0.04+300.0%	0.05	0.04	-0.03	0.01
EPS (Basic, Before Extraordinaries) per share	0.10+150.0%	0.00-100.0%	-0.01	0.04	0.04	0.04	-0.04	0.00
EPS (Diluted) per share	0.10+150.0%	0.00-100.0%	-0.01	0.04	0.04	0.04	-0.04	0.00
EBITDA	10.27+26.5%	6.20-10.1%	5.76-4.5%	7.99+17.2%	8.12+13.4%	6.90+3.0%	6.03+20.8%	6.82+83.8%
Non-Operating Income (Expense)	0.08+100.0%	0.18+800.0%	0.030.0%	-0.15	0.04-50.0%	0.02	0.030.0%	-0.05
Other After Tax Adjustments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock Option Compensation Expense	0.05-28.6%	0.05-44.4%	0.05-44.4%	0.12-50.0%	0.07-65.0%	0.09-57.1%	0.09	0.24-67.6%
Price To Earnings Ratio ratio statement ratio, not the snapshot	20.61	20.85	48.09	71.74	-	-	-	-
Price To Sales Ratio ratio	0.66	0.70	1.25	1.03	1.19	0.89	0.29	0.54
Gross Margin %	41.07	33.54	33.20	34.62	34.83	34.76	31.96	35.34
Operating Margin %	19.63	6.25	3.89	9.65	11.65	11.07	7.76	12.60
Net Margin %	12.42	0.57	-1.42	4.42	5.46	5.61	-3.12	0.04
Shares Outstanding million shares	42.55+0.4%	42.49+0.4%	42.49+0.4%	42.44+161.0%	42.40+161.4%	42.32+162.0%	42.32+162.5%	16.26+2.4%
Market Capitalization	112.33-17.3%	90.09-9.8%	155.10+163.7%	123.80+108.1%	135.85+217.4%	99.88+222.7%	58.82+214.5%	59.50+146.6%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	2025FY12/31/2025	2024FY12/31/2024	2023FY12/31/2023	2022FY12/31/2022	2021FY12/31/2021	2020FY12/31/2020	2019FY12/31/2019	2018FY12/31/2018	2017FY12/31/2017
Cash & Short Term Investments	3.62-29.6%	5.14+54.4%	3.33-72.9%	12.30+19.0%	10.34-50.6%	20.93+4.7%	19.99+38.1%	14.47+231.9%	4.36
Short Term Receivables	18.73+9.5%	17.11+0.8%	16.98-11.4%	19.17-11.8%	21.73+34.2%	16.19+72.6%	9.38-5.6%	9.94+156.2%	3.88
Inventories	0.51-10.5%	0.57+21.3%	0.47+23.7%	0.38-24.0%	0.50+25.0%	0.40-18.4%	0.49+11.4%	0.44	0.00
Other Current Assets	2.89+46.7%	1.97-19.9%	2.46-12.1%	2.80-6.0%	2.98-59.2%	7.30+540.4%	1.14-6.6%	1.22+76.8%	0.69
Total Current Assets	25.74+3.8%	24.80+6.7%	23.24-32.9%	34.65-2.6%	35.56-20.7%	44.82+44.6%	31.00+18.9%	26.07+191.9%	8.93
Net Property, Plant & Equipment	10.88+29.2%	8.42-13.0%	9.68-3.0%	9.98-19.1%	12.34-2.5%	12.66+96.9%	6.43+251.4%	1.83+31.7%	1.39
Total Investments and Advances	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	50.41+33.1%	37.88-14.4%	44.26-51.2%	90.71-1.4%	91.96+16.0%	79.27+326.0%	18.61-3.2%	19.23+30.2%	14.77
Deferred Tax Assets	0.97	0.00-100.0%	1.69+64.1%	1.03+33.8%	0.77+6.9%	0.72+56.5%	0.46+31.4%	0.35	0.00
Other Assets	0.57+11.8%	0.51-20.3%	0.64-23.8%	0.84-14.3%	0.98-21.6%	1.25+247.2%	0.36-26.5%	0.49+11.4%	0.44
Total Assets	88.56+23.7%	71.61-9.9%	79.51-42.1%	137.21-3.1%	141.61+2.1%	138.72+143.9%	56.87+18.5%	47.98+87.9%	25.53
Short Term Debt Incl. Current Port. of LT Debt	1.66+3.7%	1.60-26.6%	2.18-15.8%	2.59-39.9%	4.31-16.0%	5.13+160.4%	1.97+603.6%	0.28+64.7%	0.17
Accounts Payable	6.94+51.9%	4.57-21.2%	5.80+2.1%	5.68-4.5%	5.95-7.9%	6.46+85.1%	3.49+43.0%	2.44+146.5%	0.99
Income Tax Payable	-	-	-	0.00-100.0%	0.930.0%	0.93	-	-	-
Other Current Liabilities	15.83+18.0%	13.42-12.4%	15.32+8.5%	14.12-23.1%	18.37+11.3%	16.51+189.1%	5.71+5.0%	5.44+72.2%	3.16
Total Current Liabilities	24.42+24.7%	19.58-16.0%	23.30+4.0%	22.40-24.2%	29.56+1.9%	29.02+159.6%	11.18+37.0%	8.16+88.9%	4.32
Long Term Debt	2.63+40.6%	1.87-85.1%	12.55+11.9%	11.22-10.7%	12.56+98.1%	6.34+199.1%	2.12+863.6%	0.22+83.3%	0.12
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.97	0.00-100.0%	1.69+8.3%	1.56+28.9%	1.21+37.5%	0.88+23.9%	0.71+36.5%	0.52+40.5%	0.37
Other Liabilities	1.04+166.7%	0.39+50.0%	0.26-23.5%	0.340.0%	0.34-72.4%	1.23+6050.0%	0.02-90.5%	0.21-54.3%	0.46
Total Liabilities	29.06+33.1%	21.84-42.2%	37.80+6.4%	35.52-18.7%	43.68+16.6%	37.47+167.1%	14.03+54.0%	9.11+72.5%	5.28
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00-100.0%	0.010.0%	0.010.0%	0.010.0%	0.010.0%	0.01	0.00	0.00	0.00
Common Equity	59.50+19.5%	49.77+19.3%	41.71-59.0%	101.68+3.8%	97.93-3.3%	101.24+136.3%	42.84+10.2%	38.87+92.0%	20.25
Total Shareholders Equity	59.51+19.6%	49.77+19.3%	41.72-59.0%	101.69+3.8%	97.93-3.3%	101.25+136.3%	42.84+10.2%	38.87+92.0%	20.25
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	59.51+19.6%	49.77+19.3%	41.72-59.0%	101.69+3.8%	97.93-3.3%	101.25+136.3%	42.84+10.2%	38.87+92.0%	20.25
Total Liabilities & Stockholders Equity	88.56+23.7%	71.61-9.9%	79.51-42.1%	137.21-3.1%	141.61+2.1%	138.72+143.9%	56.87+18.5%	47.98+87.9%	25.53
Book Value Per Share per share	1.40-54.2%	3.06+16.3%	2.63-60.6%	6.68+1.8%	6.56-13.3%	7.57+116.3%	3.50+6.4%	3.29+86.9%	1.76
Tangible Book Value Per Share per share	0.21-71.2%	0.73	-0.16-122.2%	0.72+80.0%	0.40-75.6%	1.64-17.2%	1.98+19.3%	1.66+253.2%	0.47
Full-Time Employees people	3,6500.0%	3,650+1.4%	3,600-13.3%	4,150+1.2%	4,100+10.8%	3,700+37.0%	2,700+12.5%	2,400+41.2%	1,700
Price to Book Ratio ratio	4.97	1.28	0.27	0.42	0.96	1.20	1.16	1.16	1.82
Return on Assets %	13.48	10.39	-44.92	3.90	2.02	-9.01	-1.66	-5.82	-20.48
Return on Equity %	19.76	17.16	-67.88	5.44	2.85	-12.23	-2.13	-7.23	-40.74
Return on Invested Capital %	17.38	15.20	-89.69	4.81	2.57	-8.19	-1.94	-5.47	-27.32
Quick Ratio ratio	1.03	1.24	0.98	1.53	1.19	1.53	2.73	3.14	2.07
Current Ratio ratio	1.05	1.27	1.00	1.55	1.20	1.54	2.77	3.20	2.07

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	TTM	2025FY12/31/2025	2024FY12/31/2024	2023FY12/31/2023	2022FY12/31/2022	2021FY12/31/2021	2020FY12/31/2020	2019FY12/31/2019	2018FY12/31/2018
Net Income	9.66	10.80+37.6%	7.85	-48.67-996.3%	5.43+91.2%	2.84	-8.81	-0.87	-2.14
Depreciation	17.12	16.98+3.2%	16.46-3.4%	17.04+9.2%	15.60-4.0%	16.25+24.8%	13.02+162.5%	4.96+70.4%	2.91
Other Funds (Non Cash)	2.48	1.16+33.3%	0.87-98.2%	48.73+1097.3%	4.07-14.3%	4.75-30.0%	6.79+59.0%	4.27+46.7%	2.91
Funds from Operations	29.35	28.93+14.8%	25.19+52.0%	16.57-34.2%	25.18+4.4%	24.12+120.9%	10.92+29.4%	8.44+142.5%	3.48
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	-4.35	-0.37	-4.55	-1.11	-4.03	-10.79	-11.81	-0.82-124.6%	3.34
Cash from Operating Activities	25.00	28.56+38.4%	20.64+33.5%	15.46-26.9%	21.15+58.7%	13.33	-0.89-111.7%	7.62+11.9%	6.81
Capital Expenditures	-7.28	-8.03	-7.41	-11.61	-11.77	-10.56	-7.75	-2.56	-1.03
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	-12.58	-23.72	-1.60	-12.60
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Purchase or Sale of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00
Sale Or Maturity of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Uses	-1.44	-16.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Sources	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash from Investing Activities	-8.71	-24.54	-7.41	-11.61	-11.77	-23.15	-31.47	-4.16	-13.63
Cash Dividends Paid	-8.45	-6.29	0.00	-14.30	-15.31	-14.44	-11.38	-6.11	-4.10
Change in Capital Stock	-38.17	0.00	0.00-100.0%	1.43-86.8%	10.86+18.4%	9.17-81.3%	48.99+410.8%	9.59-58.0%	22.82
Repurchase of Common Pref Stock	-38.17	0.00	0.00	0.00	-20.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	0.00	0.00	0.00-100.0%	1.43-95.4%	30.87+236.6%	9.17-81.3%	48.99+410.8%	9.59-58.0%	22.82
Proceedsfrom Stock Options	0.00	0.00	0.00-100.0%	1.43-95.4%	30.87+1030.8%	2.73-93.9%	44.54+364.4%	9.59-58.0%	22.82
Issuance or Reduction of Debt, Net	30.59	0.83	-10.68-1062.2%	1.11	-1.00-114.5%	6.88	-0.67	-0.43	-0.46
Change in Long Term Debt	30.59	0.83	-10.68-1062.2%	1.11	-1.00-114.5%	6.88	-0.67	-0.43	-0.46
Issuance of Long Term Debt	51.21	10.79	0.00-100.0%	14.70	0.00-100.0%	25.92	0.00	0.00	0.00
Reduction of Long Term Debt	-20.62	-9.96	-10.68	-13.59	-1.00	-19.05	-0.67	-0.43	-0.46
Net Financing Active Other Cash Flow	-0.75	-0.15	-0.58	-1.52	-2.20	-2.12	-3.52	-1.62	-0.59
Other Financing Activities Uses	-0.75	-0.15	-0.58	-1.52	-2.20	-2.12	-3.52	-1.62	-0.59
Cash from Financing Activities	-16.78	-5.61	-11.26	-13.29	-7.65	-0.52-101.6%	33.42+2253.5%	1.42-92.0%	17.66
Exchange Rate Effect	0.05	0.06	-0.17-136.2%	0.47+104.3%	0.23	-0.25	-0.13-120.3%	0.64	-0.73
Net Change in Cash	-0.44	-1.53-184.5%	1.81	-8.97-557.7%	1.96	-10.59-1238.7%	0.93-83.2%	5.52-45.4%	10.11
Free Cash Flow	21.61	23.78+25.5%	18.95+52.8%	12.40-33.2%	18.56+78.3%	10.41	-3.48-168.8%	5.06-12.5%	5.78
Preferred Dividends (Cash Flow)	-	-6.29	0.00	-14.30	-15.31	-14.44	-11.38	-6.11	-4.10
Price to Free Cash Flow ratio	6.59	6.34	3.12	-	13.07	-	-	-	26.48
Deferred Taxes & Investment Tax Credit	-	0.00	0.00	-0.53-762.5%	0.08-72.4%	0.29	-0.08-200.0%	0.08	-0.21

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	2026Q39/30/2026	2026Q26/30/2026	2026Q13/31/2026	2025Q412/31/2025	2025Q39/30/2025	2025Q26/30/2025	2025Q13/31/2025	2024Q412/31/2024
Cash & Short Term Investments	4.64-8.5%	13.39+28.3%	3.85-43.4%	3.62-29.6%	5.07+82.4%	10.44+298.5%	6.80+64.3%	5.14+54.4%
Short Term Receivables	19.59+1.6%	17.54+0.1%	18.74+2.2%	18.73+9.5%	19.28+16.1%	17.52-2.0%	18.34+5.3%	17.11+0.8%
Inventories	0.51-15.0%	0.47-9.6%	0.43-29.5%	0.51-10.5%	0.60+17.6%	0.52+4.0%	0.61+27.1%	0.57+21.3%
Other Current Assets	3.65-15.3%	2.77+6.1%	3.06+7.0%	2.89+46.7%	4.31+56.2%	2.61-10.6%	2.86+27.7%	1.97-19.9%
Total Current Assets	28.39-3.0%	34.18+9.9%	26.09-8.8%	25.74+3.8%	29.26+29.1%	31.09+30.0%	28.62+17.9%	24.80+6.7%
Net Property, Plant & Equipment	12.08+32.7%	12.12+36.3%	12.12+43.9%	10.88+29.2%	9.10+11.0%	8.89+1.1%	8.42-11.7%	8.42-13.0%
Total Investments and Advances	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	45.89-11.2%	46.76+34.8%	47.94+32.9%	50.41+33.1%	51.67+31.5%	34.70-14.7%	36.06-15.0%	37.88-14.4%
Deferred Tax Assets	-	-	-	0.97	-	-	-	0.00-100.0%
Other Assets	0.73+32.7%	0.78+39.3%	0.57+23.9%	0.57+11.8%	0.55+1.9%	0.56-9.7%	0.46-28.1%	0.51-20.3%
Total Assets	87.10-3.8%	93.85+24.7%	86.72+17.9%	88.56+23.7%	90.58+28.1%	75.24+1.7%	73.56-4.3%	71.61-9.9%
Short Term Debt Incl. Current Port. of LT Debt	12.27+881.6%	12.33+711.2%	2.10+40.9%	1.66+3.7%	1.25-35.2%	1.52-10.1%	1.49-23.2%	1.60-26.6%
Accounts Payable	6.20-7.3%	6.07+44.2%	5.51+11.3%	6.94+51.9%	6.69+20.1%	4.21-22.8%	4.95-16.4%	4.57-21.2%
Other Current Liabilities	14.15-7.3%	15.09+43.6%	15.85+50.8%	15.83+18.0%	15.26+5.8%	10.51-34.8%	10.51-34.1%	13.42-12.4%
Total Current Liabilities	32.63+40.6%	33.49+106.2%	23.46+38.4%	24.42+24.7%	23.20+5.8%	16.24-30.1%	16.95-28.8%	19.58-16.0%
Long Term Debt	30.53+263.0%	41.69+2129.4%	3.64+102.2%	2.63+40.6%	8.41+335.8%	1.87-73.8%	1.80-84.2%	1.87-85.1%
Provision for Risks Charges	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.10	0.05	-	0.97	-	-	-	0.00-100.0%
Other Liabilities	1.22+5.2%	1.22+15.1%	1.29+104.8%	1.04+166.7%	1.16+251.5%	1.06+171.8%	0.63+103.2%	0.39+50.0%
Total Liabilities	64.47+96.7%	76.45+298.8%	28.39+46.5%	29.06+33.1%	32.77+35.5%	19.17-37.7%	19.38-45.4%	21.84-42.2%
Non-Equity Reserves	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock - Carrying Value	0.00	0.00	0.00	0.00-100.0%	0.00-100.0%	0.00-100.0%	0.00-100.0%	0.010.0%
Common Equity	22.62-60.9%	17.40-69.0%	58.33+7.7%	59.50+19.5%	57.80+24.3%	56.07+29.7%	54.17+30.8%	49.77+19.3%
Total Shareholders Equity	22.62-60.9%	17.40-69.0%	58.33+7.7%	59.51+19.6%	57.80+24.3%	56.08+29.7%	54.18+30.8%	49.77+19.3%
Accumulated Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity	22.62-60.9%	17.40-69.0%	58.33+7.7%	59.51+19.6%	57.80+24.3%	56.08+29.7%	54.18+30.8%	49.77+19.3%
Total Liabilities & Stockholders Equity	87.10-3.8%	93.85+24.7%	86.72+17.9%	88.56+23.7%	90.58+28.1%	75.24+1.7%	73.56-4.3%	71.61-9.9%
Book Value Per Share per share	0.53-61.0%	0.41-68.9%	1.37+7.0%	1.40-54.2%	1.36-52.6%	1.32-50.7%	1.28-50.2%	3.06+16.3%
Tangible Book Value Per Share per share	-0.55-492.9%	-0.69-238.0%	0.24-44.2%	0.21-71.2%	0.14-68.2%	0.50+212.5%	0.43	0.73
Full-Time Employees people	-	-	-	3,6500.0%	-	-	-	3,650+1.4%
Price to Book Ratio ratio	4.97	1.54	2.60	2.14	2.42	1.84	0.45	1.28
Return on Assets %	10.87	9.45	12.19	13.48	13.90	15.10	13.35	10.39
Return on Equity %	24.02	21.75	17.37	19.76	21.49	22.69	21.00	17.16
Return on Invested Capital %	8.89	1.90	1.49	4.65	4.62	5.01	3.48	6.38
Quick Ratio ratio	0.85	1.01	1.09	1.03	1.24	1.88	1.65	1.24
Current Ratio ratio	0.87	1.02	1.11	1.05	1.26	1.91	1.69	1.27

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric	2026Q39/30/2026	2026Q26/30/2026	2026Q13/31/2026	2025Q412/31/2025	2025Q39/30/2025	2025Q26/30/2025	2025Q13/31/2025	2024Q412/31/2024
Net Income	4.73+54.6%	1.12-61.4%	0.92-52.8%	2.89-12.4%	3.06-1.9%	2.90+73.7%	1.95	3.30
Depreciation	3.65-18.9%	4.21+8.8%	4.55+17.0%	4.72+23.6%	4.50+18.1%	3.87-10.0%	3.89-14.1%	3.82-19.6%
Other Funds (Non Cash)	1.37	0.17-46.9%	0.33-40.0%	0.61+41.9%	-0.33-162.3%	0.32-15.8%	0.55	0.43-99.0%
Funds from Operations	9.79+35.4%	5.54-21.9%	5.79-9.4%	8.22+8.9%	7.23-3.1%	7.09+11.7%	6.39+66.8%	7.55+104.1%
Extraordinary Item	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Working Capital	-4.14-3284.6%	1.53+378.1%	-2.18	0.45	0.13	0.32	-1.27-652.2%	-2.32-5900.0%
Cash from Operating Activities	5.64-23.5%	7.07-4.6%	3.61-29.4%	8.68+66.0%	7.37+4.2%	7.41+73.1%	5.11+25.6%	5.23+39.8%
Capital Expenditures	-1.85	-1.32	-1.23	-2.87	-1.70	-1.99	-1.47	-2.26
Net Assets From Acquisitions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Fixed Assets and Businesses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchase or Sale of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Purchase of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sale Or Maturity of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Uses	-0.29	-0.68	0.00	-0.47	-16.00	0.00	-0.04	0.00
Other Sources	0.00	0.00	0.00	0.00	-	-	0.00	0.00
Cash from Investing Activities	-2.14	-2.01	-1.23	-3.33	-17.70	-1.99	-1.51	-2.26
Cash Dividends Paid	-0.54	-4.52	-1.92	-1.47	-1.50	-1.59	-1.73	0.00
Preferred Dividends (Cash Flow)	-0.54	-4.52	-1.92	-1.47	-1.50	-1.59	-1.73	0.00
Change in Capital Stock	0.00	-38.17	0.00	0.00	0.00	0.00	0.00	0.00
Repurchase of Common Pref Stock	0.00	-38.17	0.00	0.00	0.00	0.00	0.00	0.00
Sale of Common Pref Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Proceedsfrom Stock Options	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Issuance or Reduction of Debt, Net	-11.67-280.1%	47.73	-0.18	-5.29	6.48	-0.17	-0.18	-0.20
Change in Long Term Debt	-11.67-280.1%	47.73	-0.18	-5.29	6.48	-0.17	-0.18	-0.20
Issuance of Long Term Debt	0.02-99.8%	48.74	0.00	2.45	8.34	0.00	0.00	0.00
Reduction of Long Term Debt	-11.68	-1.01	-0.18	-7.74	-1.87	-0.17	-0.18	-0.20
Net Financing Active Other Cash Flow	-0.06	-0.56	-0.06	-0.07	-0.05	-0.00	-0.02	-0.38
Other Financing Activities Uses	-0.06	-0.56	-0.06	-0.07	-0.05	-0.00	-0.02	-0.38
Cash from Financing Activities	-12.26-349.2%	4.47	-2.15	-6.84	4.92	-1.76	-1.93	-0.58
Exchange Rate Effect	0.00-100.0%	0.00	0.01	0.04	0.04	-0.02	-0.01	-0.03-108.6%
Net Change in Cash	-8.76	9.54+162.8%	0.24-85.5%	-1.46-161.9%	-5.37-3258.8%	3.63	1.66+104.9%	2.36
Free Cash Flow	5.32-18.2%	6.55+4.8%	3.20-28.7%	6.55+52.7%	6.50-3.4%	6.25+50.6%	4.49+19.1%	4.29+27.7%
Price to Free Cash Flow ratio	6.59	6.73	9.68	7.11	8.14	5.42	1.85	3.14

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Region
Name	2024	2025	vs 2024	2025 share
United States	110.84	120.50	+8.7%	100.0%
Total	110.84	120.50	+8.7%	100.0%

Segment
Name	2024	2025	vs 2024	2025 share
Healthcare IT	96.41	106.57	+10.5%	88.4%
Medical Practice Management	14.43	13.93	-3.5%	11.6%
Total	110.84	120.50	+8.7%	100.0%

Short interest

shares short against float, oldest to newest

Settlement	Of float	Shares short	Float	Avg volume
2026-10-30	1.90%	0.7M	35.9M	316.74K
2026-10-15	1.83%	0.7M	35.8M	313.88K
2026-09-30	1.82%	0.7M	35.8M	310.97K
2026-09-15	1.69%	0.6M	35.8M	315.26K
2026-08-31	1.51%	0.5M	35.8M	322.02K
2026-08-14	1.17%	0.4M	35.8M	335.30K
2026-07-31	1.28%	0.5M	35.8M	408.26K
2026-07-15	1.29%	0.5M	35.9M	446.57K
2026-06-30	1.13%	0.4M	35.9M	516.33K
2026-06-15	0.88%	0.3M	35.9M	615.95K
2026-05-29	1.11%	0.4M	35.9M	651.92K
2026-05-15	1.54%	0.6M	35.9M	612.14K
2026-04-30	1.43%	0.5M	35.9M	517.92K
2026-04-15	1.51%	0.5M	35.9M	503.32K
2026-03-31	1.60%	0.6M	35.9M	437.32K
2026-03-13	2.19%	0.8M	35.9M	333.94K
2026-02-27	1.58%	0.6M	35.8M	295.98K
2026-02-13	1.53%	0.5M	35.8M	316.72K
2026-01-30	1.46%	0.5M	35.8M	351.21K
2026-01-15	1.57%	0.6M	35.8M	351.91K

Option chain

expiry 2026-11-20

Type	Strike	Bid	Ask	Last	IV	Open int	Volume	Delta	Theta	Vega
call	2.50	0.15	0.35	0.25	1.825	519	25.00	0.653	-0.012	0.001
call	5.00	0.00	0.75	0.00	2.982	0.00	0.00	0.107	-0.014	0.001
call	7.50	0.00	0.95	0.00	4.219	0.00	0.00	0.084	-0.016	0.001
put	2.50	0.00	0.60	0.40	1.075	4.00	0.00	-0.347	-0.011	0.001
put	5.00	1.95	2.90	0.00	6.866	0.00	0.00	-0.893	-0.013	0.001
put	7.50	4.40	5.40	0.00	8.441	0.00	0.00	-0.916	-0.015	0.001

Latest SEC filings

Filed	Form	Description	Period	Link
2026-11-05	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-09-30	SEC
2026-11-05	8-K	Current report	2026-11-05	SEC
2026-10-05	3	Initial statement of beneficial ownership of securities	2026-10-01	SEC
2026-09-29	8-K	Current report	2026-09-28	SEC
2026-08-10	4	Statement of changes in beneficial ownership of securities	2026-08-08	SEC
2026-08-10	4	Statement of changes in beneficial ownership of securities	2026-08-08	SEC
2026-08-10	4	Statement of changes in beneficial ownership of securities	2026-08-08	SEC
2026-08-10	4	Statement of changes in beneficial ownership of securities	2026-08-08	SEC
2026-08-06	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-06-30	SEC
2026-08-06	8-K	Current report	2026-08-06	SEC
2026-07-31	4	Statement of changes in beneficial ownership of securities	2026-07-29	SEC
2026-07-31	4	Statement of changes in beneficial ownership of securities	2026-07-29	SEC
2026-07-31	4	Statement of changes in beneficial ownership of securities	2026-07-29	SEC
2026-07-31	4	Statement of changes in beneficial ownership of securities	2026-07-29	SEC
2026-07-24	4	Statement of changes in beneficial ownership of securities	2026-07-22	SEC
2026-07-24	8-K/A		2026-04-13	SEC
2026-06-26	8-K	Current report	2026-06-25	SEC
2026-06-09	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans		SEC
2026-06-05	8-K	Current report	2026-06-04	SEC
2026-05-19	FWP	Filing under Securities Act Rule 163/433 of free writing prospectuses.		SEC
2026-05-18	4	Statement of changes in beneficial ownership of securities	2026-05-15	SEC
2026-05-18	4	Statement of changes in beneficial ownership of securities	2026-05-15	SEC
2026-05-18	4	Statement of changes in beneficial ownership of securities	2026-05-15	SEC
2026-05-18	4	Statement of changes in beneficial ownership of securities	2026-05-15	SEC
2026-05-15	8-K	Current report	2026-05-15	SEC
2026-05-14	25-NSE			SEC
2026-05-14	25-NSE			SEC
2026-05-07	10-Q	Quarterly report pursuant to Section 13 or 15(d)	2026-03-31	SEC
2026-05-07	8-K	Current report	2026-05-07	SEC
2026-04-14	424B5			SEC

Insider activity by month

Month	Sold	Sells
2026-11	0	0
2026-10	0	0
2026-09	0	0
2026-08	0	0
2026-07	0	0
2026-06	0	0
2026-05	0	0
2026-04	0	0
2026-03	0	0
2026-02	0	0
2026-01	0	0
2025-12	0	0
2025-11	51.15K	1

Institutional holders

Manager	% owned
VANGUARD CAPITAL MANAGEMENT LLC	3.96%
Hillsdale Investment Management Inc.	2.16%
DIMENSIONAL FUND ADVISORS LP	1.57%
TWO SIGMA INVESTMENTS, LP	1.36%
AMERICAN CENTURY COMPANIES INC	1.16%
AMERIPRISE FINANCIAL INC	1.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.96%
GEODE CAPITAL MANAGEMENT, LLC	0.93%
WELLS FARGO & COMPANY/MN	0.91%
GLOBEFLEX CAPITAL L P	0.79%

Funds

Fund	% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND	2.90%
Avantis U.S. Small Cap Value ETF	1.11%
VANGUARD EXTENDED MARKET INDEX FUND	0.95%
Fidelity Extended Market Index Fund	0.44%
EA Bridgeway Omni Small-Cap Value ETF	0.39%
1290 Essex Small Cap Growth Fund	0.38%
Dimensional U.S. Small Cap ETF	0.31%
iShares Micro-Cap ETF	0.29%
Nationwide Bailard Small Cap Value Fund	0.23%
Ultra-Small Company Fund	0.22%

OakChart. CCLD. Cached 15 minutes. Terms